12–1pm 25 October 2017
Role of Innate Lymphoid Cells in Vaccination
Mr Zhei (Jerry) Li, The Ranasinghe Group, JCSMR
Final PhD Seminar
3.30–4.30pm 26 October 2017
Targeting Eph receptor and ADAM metalloprotease function in cancer
Dr Peter Janes, Monash University, Melbourne, VIC
Dr Janes works on fundamental systems present at the surface of all cells, but particularly cancerous...
12–1pm 27 October 2017
Professor John Christodoulou FAHMS, Chair of Genomic Medicine, Department of Paediatrics, University of Melbourne, and Head, Neurodevelopmental Genomics Research Group, and Director of the Genetics Research Theme, Murdoch...
5.30–6.15pm 30 October 2017
Professor David Tscharke, Head, Department of Immunology and Infectious Disease, The John Curtin Schoool of Medical Research, ANU
Even when we are healthy, we are silent hosts for many viruses. Viruses from the herpes family...
12–1pm 3 November 2017
Professor Ruth Ganss, Harry Perkins Institute of Medical Research/University of Western Australia
Intratumoral inflammation fosters angiogenesis and creates an immunosuppressive milieu. The self-amplifying loop of pro-...
12–1pm 10 November 2017
Professor Mark Smyth, QIMR Berghofer Medical Research Institute, QLD
Professor Mark Smyth is a Senior Scientist and Immunology Coordinator at QIMR Berghofer Medical Research Institute. He completed his PhD in 1988 and trained...
12–1pm 24 November 2017
Professor Lars Nitschke, PhD, Division of Genetics, Department of Biology, University of Erlangen, Germany
The Nitschke group works on Siglec proteins, which are inhibiting receptors on immune cells that can bind sialic...
12–1pm 15 December 2017
Dr James Wang, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA
Activated B cell like diffuse large B cell lymphoma (ABC-DLBCL) is an aggressive and incurable form of B cell malignancy. A hallmark...